Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series.

By Sonali M. Smith, M. L. Le Beau, D. Huo, T. Karrison, R. Sobecks, J. Anastasi, J. Vardiman, J. Rowley, R. Larson. Blood, 2003

697 citations recorded by the source corpus.

Subfields: Hematology, Public Health, Environmental and Occupational Health

View Paper: https://www.semanticscholar.org/paper/dd8caf90e7794e7bc6572248aa2c60c3137d5256

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. N. Vey
2. V. Gelsi-Boyer
3. M. Mozziconacci
4. S. Olschwang
5. L. Xerri
6. T. Prebet
7. J. Adélaïde
8. Julien Bonansea

Citations in the corpus

• Mutations of polycomb‐associated gene ASXL1 in myelodysplastic syndromes and chronic myelomonocytic leukaemia (2009, background): “They are found by conventional cytogenetics in 40–70% of de novo MDSs and in 95% of secondary MDSs (Heim, 1992; Smith et al, 2003; Fenaux, 2004; Bennett & Komrokji, 2005).”